Items where authors include "Acharya, KR"
Article
Cozier, GE, Newby, EC, Schwager, SLU et al. (3 more authors) (2022) Structural basis for the inhibition of human angiotensin-1 converting enzyme by fosinoprilat. The FEBS Journal, 289 (21). pp. 6659-6671. ISSN 1742-464X
Cashman, JS, Cozier, GE, Harrison, C et al. (2 more authors) (2019) Crystal structures of angiotensin-converting enzyme from Anopheles gambiae in its native form and with a bound inhibitor. The Biochemical journal, 476 (22). pp. 3505-3520. ISSN 0264-6021
Monaghan, TM, Negm, OH, MacKenzie, B et al. (5 more authors) (2017) High prevalence of subclass-specific binding and neutralizing antibodies against Clostridium difficile toxins in adult cystic fibrosis sera: possible mode of immunoprotection against symptomatic C. difficile infection. Clinical and Experimental Gastroenterology, 10. pp. 169-175. ISSN 1178-7023
Abu Hasan, Z, Williams, H, Ismail, NM et al. (4 more authors) (2017) The toxicity of angiotensin converting enzyme inhibitors to larvae of the disease vectors Aedes aegypti and Anopheles gambiae. Scientific Reports, 7. 45409. ISSN 2045-2322
Iyer, S, La-Borde, PJ, Payne, KAP et al. (4 more authors) (2015) Crystal structure of X-prolyl aminopeptidase from Caenorhabditis elegans: A cytosolic enzyme with a di-nuclear active site. FEBS Open Bio, 5. 292 - 302. ISSN 2211-5463
Proceedings Paper
Monaghan, TM, Negm, O, MacKenzie, B et al. (5 more authors) (2017) HIGH PREVALENCE OF SUBCLASS-SPECIFIC BINDING AND NEUTRALISING ANTIBODIES AGAINST CLOSTRIDIUM DIFFICILE TOXINS IN ADULT CYSTIC FIBROSIS SERA: POSSIBLE MODE OF PROTECTION AGAINST SYMPTOMATIC CLOSTRIDIUM DIFFICILE INFECTION. In: Gut. British Society of Gastroenterology Annual General Meeting, 19-22 Jun 2017, Manchester, UK. BMJ Publishing Group , A133-A134.
Monaghan, TM, Jilani, T, Hamed, M et al. (11 more authors) (2017) A Protein Microarray Assay For Predicting Severe Outcomes in Clostridium Difficile Infection. In: Gut. British Society of Gastroenterology Annual General Meeting, 19-22 Jun 2017, Manchester, UK. BMJ Publishing Group , A31-A31.